Cambridge Nutritional Sciences plc

DB:RVKA Stock Report

Market Cap: €9.2m

Cambridge Nutritional Sciences Past Earnings Performance

Past criteria checks 0/6

Cambridge Nutritional Sciences has been growing earnings at an average annual rate of 4.9%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 0.8% per year.

Key information

4.9%

Earnings growth rate

15.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-0.8%
Return on equity-3.4%
Net Margin-3.4%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Cambridge Nutritional Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:RVKA Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2410070
31 Dec 239-270
30 Sep 239-370
30 Jun 238-370
31 Mar 238-360
31 Dec 228-360
30 Sep 228-360
30 Jun 228-260
31 Mar 229-160
30 Sep 218140
30 Jun 217140
31 Mar 217050
31 Dec 209-470
30 Sep 209-770
30 Jun 209-770
31 Mar 2010-770
31 Dec 199-470
30 Sep 199060
30 Jun 199060
31 Mar 199060
31 Dec 188-160
30 Sep 188-270
30 Jun 188-170
31 Mar 188-170
31 Dec 1710070
30 Sep 1712080
30 Jun 1713080
31 Mar 1714190
31 Dec 1614180
30 Sep 1613180
30 Jun 1613180
31 Mar 1613180
31 Dec 1513180
30 Sep 1513170
30 Jun 1512170
31 Mar 1512170
31 Dec 1412170
30 Sep 1412170
30 Jun 1412170
31 Mar 1412170
31 Dec 1311170

Quality Earnings: RVKA is currently unprofitable.

Growing Profit Margin: RVKA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RVKA is unprofitable, but has reduced losses over the past 5 years at a rate of 4.9% per year.

Accelerating Growth: Unable to compare RVKA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RVKA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: RVKA has a negative Return on Equity (-3.39%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies